Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Lung Neoplasms × Diet × Clear all

Phase

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 11 Polycystic Ovary Syndrome 8 Breast Neoplasms 8 Obesity 7 Colorectal Neoplasms 5 Weight Loss 4 Colonic Neoplasms 4 Prostatic Neoplasms 3 Multiple Endocrine Neoplasia Type 1 3 Endometrial Neoplasms 3 Pancreatic Neoplasms 2 Overweight 2 Neoplasms 2 Malnutrition 2 Lymphoma, Follicular 2 Lymphoma 2 Carcinoma, Intraductal, Noninfiltrating 2 Waldenstrom Macroglobulinemia 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sexual Dysfunction, Physiological 1 Sarcopenia 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Patient Compliance 1 Pancreatitis, Chronic 1 Ovarian Neoplasms 1 Myelodysplastic Syndromes 1 Metabolic Syndrome 1

Interventions

Carboplatin 295 Cisplatin 218 Radiotherapy 177 Paclitaxel 174 Pemetrexed 165 Docetaxel 156 Gemcitabine 139 pembrolizumab 126 Erlotinib Hydrochloride 98 Etoposide 89 Magnetic Resonance Spectroscopy 83 Bevacizumab 75 Specimen Handling 67 durvalumab 64 Radiosurgery 63 Nivolumab 63 Vinorelbine 50 Drug Therapy 46 osimertinib 45 Gefitinib 42 Irinotecan 37 Biopsy 36 Topotecan 35 Radiation 35 Cyclophosphamide 35 atezolizumab 34 Standard of Care 33 Cetuximab 31 Blood Specimen Collection 30 Immunoglobulin G 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03785808 2019-08-12

RIGHT

Fred Hutchinson Cancer Center

Phase NA Terminated

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡